A preliminary study on the combined assessment of 25-hydroxyvitamin D and thyroid function for predicting diabetic foot risk and amputation in type 2 diabetes - Summary - MDSpire

A preliminary study on the combined assessment of 25-hydroxyvitamin D and thyroid function for predicting diabetic foot risk and amputation in type 2 diabetes

  • By

  • Dan Xiong

  • Yuanfang Jiang

  • Zhengxia Yu

  • Yaqin Zhong

  • Ke Peng

  • Xianglong Xia

  • Youqi Zhang

  • Lijun Liu

  • Weixia Peng

  • June 15, 2026

  • 0 min

Share

Objective:

To examine the disparities in 25-hydroxyvitamin D (25OH-vitD) levels and thyroid function between patients with type 2 diabetic foot (DF) and those with type 2 diabetes (T2DM), and to evaluate the predictive value of 25OH-vitD combined with thyroid function for DF and its impact on amputation.

Approach:
    Key Findings:
    • DF patients had significantly lower serum 25OH-vitD and FT3 levels compared to T2DM patients.
    • The deficiency group of 25OH-vitD (<20 ng/mL) had a higher risk of DF (OR = 3.539).
    • FT3 was identified as an independent protective factor (OR = 0.493).
    • ROC analysis showed AUC for combined predicted probability was 0.701.
    • ESS group had lower 25OH-vitD levels and higher amputation rates compared to the euthyroid group.
    Interpretation:

    Remove this section.

    Limitations:
    • The study is retrospective and may have selection bias.
    • Sample size is limited to 158 patients.
    Conclusion:

    Revise to focus solely on findings without implications.

Original Source(s)

Related Content